LRkXNZ6CdK6tnVmQilJbxeLCEIO3Jfblzvz5hSCbL1NYzhlOmEdUtEAzj5I9

Paper Publications

Home >> Scientific Research >> Paper Publications

SREBF2-STARD4 axis confers sorafenib resistance in HCC by regulating mitochondrial cholesterol homeostasis.

Release Time:2022-12-03| Hits:

Institution:基础医学院

Title of Paper:SREBF2-STARD4 axis confers sorafenib resistance in HCC by regulating mitochondrial cholesterol homeostasis.

Journal:CANCER SCIENCE

Key Words:SREBF2;StARs;cholesterol transport;mitochondrial membrane permeability;sorafenib resistance

First Author:岳学田

Document Code:1543789209468289025

Number of Words:5000

Translation or Not:No

Date of Publication:2022-05

Release Time:2022-12-03

Prev One:
Tim-4 reprograms cholesterol metabolism to suppress antiviral innate immunity by disturbing the Insig1-SCAP interaction in macrophages
Next One:
Multi-Omics Analysis of Fatty Acid Metabolism in Thyroid Carcinoma

中文    |   MOBILE Version   |   Login   |   SDU   

Copyright All Rights Reserved Shandong University Address: No. 27 Shanda South Road, Jinan City, Shandong Province, China: 250100
Information desk: (86) - 0531-88395114
On Duty Telephone: (86) - 0531-88364731 Construction and Maintenance: Information Work Office of Shandong University

Click: Times

The Open Time: --

The Last Update Time: --